skip to main |
skip to sidebar
New Compound Safely Reduces Plaques in Mouse Model of Alzheimer's Disease
ScienceDaily (Sep. 8, 2010) — A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).
No comments:
Post a Comment